Us of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)

Details for Australian Patent Application No. 2006201058 (hide)

International Classifications

Event Publications

30 March 2006 Application Open to Public Inspection

Published as AU-B-2006201058

30 March 2006 Complete Application Filed

15 February 2007 Assignment before Grant

Pharmagene Laboratories Ltd The application has been assigned to Novartis International Pharmaceutical Ltd.

22 March 2007 Amendment Made

The nature of the amendment is: Amend the name of the co-inventors to read Page, Keith John and Davis, Richard Jon

3 May 2007 Application Accepted

Published as AU-B-2006201058

31 May 2007 Amendment Made

The nature of the amendment is: Amend the invention title to read Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)

30 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.